Kymera Therapeutics Inc. (NASDAQ:KYMR) announced positive first-in-human results from its Phase 1 healthy volunteer clinical ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

The investigational drug demonstrated robust STAT6 degradation in blood and skin that was well tolerated and safe in healthy ...

The League of Legends Champions Korea (LCK) will hold its 2025 Mid-Season Invitational representative selection beginning ...

The candidate is being positioned as a potential oral competitor to Sanofi and Regeneron's blockbuster Dupixent in allergy ...

Kymera Therapeutics shares rose after it disclosed positive clinical results from the Phase 1 healthy volunteer study of KT-621. Shares were up 13% to $33.49 in premarket trading on Monday. KT-621 is ...

Korean and Vietnamese telcos KT and Viettel have signed a partnership worth KRW 130bn ($94.6m) to promote AI technologies in ...

Russell County Hospital, in partnership with the Association of Health Plans (KAHP), has announced plans to launch a new Food ...

In a landmark move to spotlight emerging talent across the Emirates, Khaleej Times is proud to announce the launch of the KT ...

KT Cloud has completed its 10MW data center in Yecheon-gun, Gyeongsangbuk-do, South Korea. The company held a completion ...

Working President KT Rama Rao (KTR) inaugurated the Knowledge Centre of Pragmatic Design Solutions Limited (PDSL) in Warwick, ...

The Department of Fish and Wildlife Resources (KDFWR) says “Step aside, Black Friday and Cyber Monday, as you just can’t top ...